1. Home
  2. VERA vs HTH Comparison

VERA vs HTH Comparison

Compare VERA & HTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$49.95

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Hilltop Holdings Inc.

HTH

Hilltop Holdings Inc.

HOLD

Current Price

$34.81

Market Cap

2.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERA
HTH
Founded
2016
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
2.1B
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
VERA
HTH
Price
$49.95
$34.81
Analyst Decision
Strong Buy
Hold
Analyst Count
10
2
Target Price
$67.67
$34.00
AVG Volume (30 Days)
1.8M
391.5K
Earning Date
11-05-2025
01-29-2026
Dividend Yield
N/A
2.06%
EPS Growth
N/A
53.28
EPS
N/A
2.50
Revenue
N/A
$1,259,399,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.64
P/E Ratio
N/A
$13.98
Revenue Growth
N/A
7.66
52 Week Low
$18.53
$26.67
52 Week High
$50.16
$36.14

Technical Indicators

Market Signals
Indicator
VERA
HTH
Relative Strength Index (RSI) 84.03 59.44
Support Level $40.38 $34.63
Resistance Level $47.10 $35.65
Average True Range (ATR) 3.41 0.72
MACD 1.34 0.03
Stochastic Oscillator 99.88 77.29

Price Performance

Historical Comparison
VERA
HTH

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About HTH Hilltop Holdings Inc.

Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.

Share on Social Networks: